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Abstract
Background:  Canadian hysterectomy rates have declined in recent years. However,
hysterectomy rates for discretionary indications, principally abnormal uterine bleeding (AUB),
remain high in some regions. In northern Ontario, hysterectomy rates for women aged 34–45 are
almost triple the rates in southern, urban areas. Primary care physicians (family doctors) usually
manage AUB initially in these northern areas where a severe shortage of gynecologists exists.
Methods: We surveyed 194 family physicians in northern Ontario with a case scenario of a pre-
menopausal woman with heavy vaginal bleeding to characterize management and to gain physicians'
perspectives on the factors that affect it.
Results: To investigate her heavy vaginal bleeding, only 17% of physicians recommended a pelvic
examination for the woman in our case scenario. Most physicians advocated a course of medical
therapy before referral to a gynecologist, for whom the average waiting time was seven weeks.
However, most physicians recommended referral after only one failed trial of medical treatment.
Physicians felt that major deterrents to medical treatments were patient desires for immediate
relief and/or permanent solutions, poor patient compliance and the high cost of medication. Only
25% of respondents indicated that they would perform an endometrial biopsy prior to referral.
Conclusions:  Family physicians would benefit from further education on appropriate
investigations for AUB, primarily training in pelvic examination and endometrial biopsy techniques,
as well as appropriate treatment algorithms. Further research into patient perspectives on
treatment options is needed.
Background
Although hysterectomy rates have declined in developed
countries over the past ten years, several countries includ-
ing the United States, Canada and Australia have much
higher rates than most European countries and report
large variations in rates by region [1,2]. In Canada, for ex-
ample, the age-adjusted hysterectomy rate for women
aged 34–45 in some northern and rural areas of Ontario
is nearly triple that in urban areas such as Toronto. The
differences between regions are largely attributable to a
higher rate of hysterectomies being performed for discre-
tionary indications, primarily for abnormal uterine bleed-
ing (AUB) that is unrelated to a systemic cause,
anatomical lesion or malignancy [2]. Clinical practice
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guidelines conclude that hysterectomy is indicated prima-
rily for women with AUB who have not had an adequate
response to medical treatment or other surgical interven-
tions [3–5]. The reasons for the increased regional hyster-
ectomy rates are likely to involve physician, patient and
economic factors. AUB is a common problem and accord-
ingly primary care physicians (family doctors) are often
responsible for its management, especially in northern
and isolated areas where a severe shortage of gynecolo-
gists exists. It is essential that family doctors are confident
in providing initial investigation and treatment for wom-
en who present with abnormal uterine bleeding. The
present study characterizes the management patterns of
primary care physicians in northern Ontario who re-
sponded to a survey and gains their perspectives on the
factors that affect their management of AUB.
Methods
A five-page questionnaire entitled "Management of Heavy
Vaginal Bleeding: Northern and Rural Primary Care Phy-
sicians" was developed in June, 2000 on the basis of the
current accepted standards for the management of AUB
and recommendations for hysterectomy (Keywords: Men-
orrhagia, Hysterectomy andAbnormal Uterine Bleeding) [6].
Clinical practice guidelines on AUB and hysterectomy
were sought from the Society of Obstetricians and Gyne-
cologists of Canada (SOGC) and the American College of
Obstetricians and Gynecologists (ACOG). The guidelines
available at the time of survey development had been
published in 1996 (SOGC) and 1994 (ACOG) [3,7,8]. In-
put from family physicians, gynecologists, sociologists,
psychologists and other women's health experts was in-
corporated during the survey development and piloting.
The survey (see appendix – additional file 1) was com-
posed of four parts, of which I. Demographic Information
and II. Clinical Scenario, Investigations and Treatment are
reported in this paper. Parts III. Clinical Practice Guide-
line Use and IV. Education and Resource Needs Assess-
ment are described in the accompanying article ("Part II:
What Do We Need?").
We collected information on physicians' sex, age, history
of clinical practice, Internet access (for availability of in-
formation), previous obstetrical experience (possible in-
dication of comfort level with managing gynecological
problems) and Canadian College of Family Physicians
(CCFP) membership status (requirements for continuing
medical education (CME) and access to CME resources).
In the clinical scenario, a 39 year old woman presents
with heavy cyclic vaginal bleeding of 3 months duration
which impacts her daily function. Family physicians were
asked what investigations they would perform and assum-
ing that the results of all investigations were normal (i.e.
that the cause of the bleeding was not identifiable), to out-
line their first, second and third lines of treatment.
The questionnaire was mailed to 686 physicians in the
northern Ontario regions in the three district health coun-
cils that have the highest rates of hysterectomy[2]. Physi-
cians were identified with the help of the Northern Shores
District Health Council, the College of Physicians and
Surgeons of Ontario (CPSO) web page and the local Yel-
low Pages. Each package included a cover letter explaining
the objectives of the study, a questionnaire and a stamped
return envelope. A modification of the Dillman (TDM)
approach was used with two reminders, sent 3 and 8
weeks respectively after the original, each including a re-
placement questionnaire and a reminder letter [9]. Fifty-
four surveys were returned due to incorrect address or spe-
cialty information (i.e. respondents were not family phy-
sicians). There were 194 completed responses from the
remaining 622 potential participants (Response Rate =
31%). Response rates were evenly distributed among the
three health regions and all respondents were family phy-
sicians currently practicing in northern, rural and/or iso-
lated areas.
The Statistical Package for the Social Sciences (SPSS, ver-
sion 10) was used for statistical analysis. Investigation and
treatment recommendations generated by physicians
were coded into individual variables. Descriptive analyses
of all continuous and categorical variables were conduct-
ed. Chi square tests of independence investigated whether
responses were dependent on sex, Internet use, previous
obstetrical experience or Canadian College of Family Phy-
sicians (CCFP) membership status. Independent sample
t-tests and analyses of variance (ANOVA) were used to de-
termine any differences in responses by age or the popu-
lation of the physician's practice location.
Results
Physician information
Responding physicians, mean age 43.4 +/- 10.5 years, had
been in family practice an average of 14.9 +/-10.8 years.
Corresponding to the gender distribution of physicians in
Ontario, 37.5% of the respondents were female, 62.5%
were male. Males were significantly older with more years
in family practice than females (t = -4.612, p = 0.00; t = -
4.324, p = 0.00). All physicians practiced in northern On-
tario, with 45.1% also designating their practice popula-
tions as "rural" and 17.5% as "isolated". These categories
were not mutually exclusive (i.e. a physician could prac-
tice in an area that is rural and isolated). Fifty percent of
physicians were practicing in areas with populations of
less than 15 000 people, with the remainder in larger
towns (25%) or small cities (25%). Three-quarters of the
respondents were members of the Canadian College of
Family Physicians (CCFP) indicating completion of aBMC Women’s Health 2002, 2 http://www.biomedcentral.com/1472-6874/2/10
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family practice residency, successful passing of an exami-
nation in family practice and participation in continuing
medical education (CME). A higher proportion of women
were members of the CCFP than men in keeping with
their younger age (χ2 = 13.8, p = 0.00). With respect to ob-
stetric experience, 41.4% had previously delivered babies
in their practices, 32.5% were currently doing deliveries
and 26.2% had never delivered babies in their practices.
Almost all (92.7%) respondents had Internet access either
in their homes or offices.
Investigations and treatment
Investigations suggested by physicians are reported in Ta-
ble 1. The tests recommended most frequently were pelvic
ultrasounds (87.1%), complete blood counts (75.3%)
and thyroid function tests (41.2%). Endometrial biopsy
(EB) was recommended by 25.3%, and dilatation and cur-
retage (D&C) by 24.2%, of physicians either during the in-
itial investigation or after treatment failure. Older
physicians were more likely to recommend D&C than
younger physicians (t = 2.28, p = 0.02) and women phy-
sicians were more likely to recommend EB than men (χ2
= 5.13, p = 0.02). Seventeen percent of physicians indicat-
ed that they would perform a pelvic exam on the patient
in the clinical scenario, with a greater proportion of non-
CCFP members recommending pelvic exams than CCFP
members (χ2 = 6.83, p 0.009). Some respondents
(15.5%) recommended coagulation testing. These physi-
cians were significantly younger than physicians who did
not order the aforementioned tests (t = -2.51, p = 0.015).
Table 2 presents physician treatment patterns for first, sec-
ond and third lines of treatment. Medical options were
the most highly recommended first and second lines of
treatment. Physicians who chose medical options as a first
line of treatment were significantly younger than those
who did not (mean age 42 versus 50, t=-4.1, p = 0.00) and
had been in family practice for less time (13.6 versus 22.5
years, t = -4.1, p = 0.00). Oral contraceptives (54%) and
non-steroidal anti-inflammatory drugs (26%) were the
most popular recommendations. A second trial of medi-
cal therapy was recommended most frequently by female
physicians and CCFP members. Family doctors who prac-
tice obstetrics were more likely than those who did not, to
recommend a third trial of medical therapy (χ2 = 6.47, p
= 0.01).
Physicians who recommended immediate referral to a
gynecologist (9.3%) were significantly older, and had
been in practice longer, than those who did not. Male
physicians and non-CCFP members were more likely to
refer after the failure of only one trial of medical treat-
ment. Upon failure of a second medical treatment, 84% of
physicians who had not yet referred the patient to a gyne-
cologist did so. Of these referring physicians, 20% specif-
ically recommended hysterectomy (note that physicians
were not asked to speculate on the outcome of a referral).
Average waiting time for a gynecological referral for a
woman with AUB was approximately 7 weeks (range = 28
weeks) and more than 50% of patients would have to
commute for at least one hour to attend a gynecologist.
Physicians identified several patient factors as deterrents
to medical and/or hormonal management of AUB (Table
3). Major deterrents to medical management were a desire
for immediate relief (70.8%), poor compliance (51.9%)
and that it might not be a permanent solution (49.7%).
Another deterrent was financial impact on patients
(31.9%) and this was cited more often by physicians who
practiced in areas with smaller populations (t = -3.30, p =
0.001).
Discussion
The study's response rate (31%) illustrates one of the
greatest challenges in improving the management of AUB,
that is, to communicate with all family physicians who
manage this problem, both to determine their needs and
to disseminate information. Current lists of active family
doctors practicing in the North are difficult to obtain as
there is a rapid turnover of physicians and this presents a
challenge for surveys and education. The physicians who
Table 1: Investigations: Physician Recommendations (N = 194)
Investigation N (%)
Pelvic ultrasound 169 (87.1)
Complete blood count (cbc) 146 (75.3)
Thyroid function tests 80 (41.2)
Endometrial biopsy* 49 (25.3)
Iron and/or serum ferritin 48 (24.7)
Dilatation and curettage* 47 (24.2)
International normalized ratio 
(INR)/ prothrombin time (PT)
46 (23.7)
Platelets 46 (23.7)
Pap smear 45 (23.2)
Pelvic exam 33 (17.0)
Partial thromboplastin time 30 (15.5)
Follicle stimulating hormone (FSH) 22 (11.3)
Luteinizing hormone (LH) 18 (9.3)
Glucose 10 (5.2)
Abdominal exam 8 (4.1)
Estrogen 8 (4.1)
Pregnancy test (beta HCG) 8 (4.1)
Prolactin 7 (3.6)
Progesterone 4 (2.1)
Referral (no investigations) 4 (2.1)
* requested either during initial investigation or during course of 
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responded to this questionnaire may be more highly mo-
tivated and a more geographically stable group than the
average. As three-quarters of them were members of the
College of Family Physicians they accordingly may repre-
sent a more highly trained, younger and possibly more
knowledgeable subset of the practicing regional general
practitioners. With this in mind, the authors take caution
in interpreting the results of this questionnaire. However,
as physicians who are practicing medicine in the northern,
rural and isolated regions are all affected by problems
such as time pressure and lack of resources, the issues
identified by our respondents may be the tip of the ice-
berg.
To identify areas where responding physicians can im-
prove their management of AUB, we compared their rec-
ommended investigation and treatment responses to best
evidence guidelines or algorithms available at the time
that the survey was conducted. Since this time, clinical
practice guidelines on the investigation and management
of AUB have been updated [5,6]. However, as the majority
of respondents were unaware of any existing guidelines at
the time of our survey, it is unlikely that they have signif-
icantly changed their practices in light of the new ones
(see accompanying article).
Current clinical practice guidelines (CPGs) recommend a
pelvic exam to visualize the cervix and palpate pelvic
masses, however, only 17% of respondents indicated that
they would do this. These physicians may not be confi-
dent in their pelvic exam skills or perhaps believe that a
pelvic exam can be replaced by pelvic ultrasound (suggest-
ed by 87% of physicians). Pelvic exam training and iden-
tification of cervical lesions and uterine fibroids would
allow further specific investigation and treatment to be in-
stituted earlier for affected women thereby decreasing the
need for unnecessary investigations and costs to the pa-
tients and the health care system.
Appropriately, the majority of family physicians suggested
a complete blood count to look for an anemia. Thyroid
function tests, recommended by almost half of the re-
sponding physicians, and coagulation tests (recommend-
ed by 15.5%) should be considered when there is clinical
suspicion of thyroid dysfunction or bleeding disorders re-
spectively. Identification and appropriate treatment of
thyroid dysfunction and bleeding disorders may reduce
the necessity for surgical intervention in AUB. Tests of fol-
Table 2: Treatment Pattern for AUB.
Treatment First Line
Frequency (%)
Second Line
Frequency (%)
Third Line
Frequency (%)
Watchful Waiting 7 (3.6) 1 (0.5) 0 (0)
Medical
Oral Contraceptive 105 (54) 51 (28) 3 (2.4)
NSAID 50 (26) 8 (4.4) 1 (0.8)
Progesterone alone 22 (11) 33 (18) 6 (4.8)
Estrogen alone 2 (1.0) 0 (0) 0 (0)
Anti-fibrinolytic 2 (1.0) 2 (1.1) 4 (3.2)
Gonadotropin Agonist 3 (1.5) 6 (3.3) 6 (4.8)
Referral 18 (9.3) 88 (48) 106 (84)
Surgical
Dilatation and Curettage 6 (3.1) 31 (17) 10 (7.9)
Endometrial Ablation 1 (0.5) 10 (5.5) 13 (10)
Hysterectomy 2 (1.0) 10 (5.5) 25 (20)
Total Respondents 194 183 126
Table 3: Deterrents to Medical or Hormonal Management of 
AUB: Patient Factors (N = 185)
Deterrent N (%)
Desire for immediate relief 131 (70.8)
Poor compliance 96 (51.9)
May not be a permanent solution 92 (49.7)
Financial impact 59 (31.9)
Limited patient comprehension 52 (28.1)
Patient's partner's preferences 23 (12.4)
Distance patient lives from medical care 15 (8.1)
Transportation problems 13 (7.0)
Embarrassment or offence of patient 12 (6.5)
Other: contraindications, side effects, cultural/
religious beliefs, family planning, health beliefs (i.e. 
that medication won't work)
N/ABMC Women’s Health 2002, 2 http://www.biomedcentral.com/1472-6874/2/10
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licle stimulating hormone (FSH) and luteinizing hor-
mone (LH), recommended by 11.3% and 9.3% of
respondents respectively, are more useful in the clinical
context of examining ovarian function.
Whether endometrial sampling to look for endometrial
hyperplasia or neoplasia was necessary in this scenario is
a controversial point. Guidelines in existence at the time
of the study stated that endometrial sampling should be
done in any pre-menopausal woman with heavy vaginal
bleeding who is refractory to treatment [3]. More specifi-
cally, recent guidelines (2002) support endometrial sam-
pling in premenopausal women with AUB who are over
forty years of age, who have risk factors for endometrial
cancer including new onset of heavy, irregular bleeding or
whose bleeding is refractory to three months of medical
therapy [4]. As the woman in our case scenario had cyclic
bleeding, endometrial sampling may not have been nec-
essary in the initial management plan, yet less than half
the respondents recommended endometrial sampling at
any time during her management, even after she did not
improve with treatment.
Endometrial biopsy (EB) is the initial diagnostic endome-
trial sampling procedure of choice for detecting endome-
trial hyperplasia or neoplasia (sensitivity 67–95%).
Diagnostic D&C has a lower sensitivity and higher proce-
dural risk (e.g. uterine perforation, hemorrhage, anesthet-
ic complications) and it is only recommended when no
other sampling methods are feasible. Pelvic ultrasound is
neither sensitive nor specific for endometrial carcinoma
in premenopausal women and can therefore not be used
as a form of endometrial sampling [10]. EB can be per-
formed in-office by family physicians and having the abil-
ity to rule out endometrial hyperlasia and neoplasia will
allow medical treatments to be attempted, possibly reduc-
ing gynecological referral rates in the long-term.
Most respondent physicians advocated for at least one
course of medical therapy before referring the patient to a
gynecologist and/or recommending surgical intervention.
It is not surprising that younger family doctors were most
likely to recommend initial medical treatment as they
have the greatest proximity to their medical training and
AUB management has changed in recent years. Further,
CCFP members (who have continuing medical education
requirements) and those practicing obstetrics (who likely
have a high proportion of women in their practices and
may be more confident and up-to-date on obstetrical and
gynecological issues) were most likely to recommend sub-
sequent medical treatments. This highlights the impact of
knowledge and confidence on physician management
patterns.
Many physicians reported that patient desire for immedi-
ate relief and permanent solutions were deterrents to
medical or hormonal treatment. However, the waiting
time for a gynecological referral could encompass several
cycles of heavy bleeding and missed work. By this point,
an untreated woman experiencing significant frustration
and distress may have an increased wish for a definitive
treatment, such as hysterectomy [11]. Poor compliance
was anticipated as a deterrent to medical management by
over half of responding physicians. Therefore, it is impor-
tant to educate women about the medications and their
effects. Physician perceptions of patient deterrents to
medical management must be further confirmed with pa-
tients in order to design appropriate interventions.
Conclusions
Evidence and opinion on the management of AUB chang-
es rapidly and the efforts in the management of AUB by al-
ready overburdened primary care physicians in northern,
rural and isolated areas should be commended. However,
family physicians would benefit from further education
on appropriate investigations and treatment for AUB,
training and practice in pelvic exam and endometrial bi-
opsy techniques. As well, women may not have all of the
facts about medical and surgical treatment options and
this is an opportunity for primary care physicians to help
women obtain the best information to make effective
treatment decisions. Specific suggestions for the form and
dissemination of these recommendations are found in the
accompanying article.
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Appendix
Clinical scenario
A 39-year old woman presents with a three-month history
of cyclic, heavy vaginal bleeding every 24 days. She is
without pain, bowel or bladder complaints. However, her
heavy bleeding prevents her from going to work 4–6 days
per cycle. She has no history of medical problems and is
not taking any medications. She has only been hospital-
ized once, for the uncomplicated birth of her only child,
3 years ago. For the past 5 years, on pelvic examination,
she has had a fibroid the size of an 8-week pregnancy.
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